Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Merilee Raines currently holds 21,214 shares of OCULAR THERAPEUTIX, INC (OCUL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Merilee Raines has been a net seller of OCUL stock. They have purchased $0 and sold $39.6M worth of shares.
Merilee Raines's most recent insider trade was on Aug 5, 2025, when they sold 516 shares at $0.00 per share.
Merilee Raines serves as Executive at OCULAR THERAPEUTIX, INC (OCUL). They have executed 149 insider transactions totaling $39.6M over their tenure at the company.
Merilee Raines holds the position of Executive at OCULAR THERAPEUTIX, INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Merilee Raines has shown a selling trading pattern, with $0 in total purchases and $39.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Merilee Raines was on Feb 4, 2013, when they sold $7.9M worth of IDXX shares. This transaction involved 84,486 shares at $93.63 per share.
Merilee Raines currently owns 21,214 shares of OCULAR THERAPEUTIX, INC (OCUL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Merilee Raines's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Merilee Raines has 149 Form 4 filings on record as an insider at OCULAR THERAPEUTIX, INC.
Set alerts for Merilee Raines and 40,000+ other insiders.